Evofem Biosciences (EVFM) Cash & Equivalents (2014 - 2026)
Evofem Biosciences' Cash & Equivalents was $1.49 million in Q1 2026, up 574.7% from $221,000 a year earlier and up 158.0% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Evofem Biosciences came in at $578,000, down 22.0% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -58.8% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $741,000 in FY2024, $2.77 million in FY2022 (-64.2%) and $7.73 million in FY2021 (-84.2%).
- The Q1 2026 figure marks the highest quarterly Cash & Equivalents since Q4 2022.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2026 (growth of 574.7%); the worst was Q1 2022 (a decline of 93.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.49 Mn |
| Dec 31, 2025 | 578,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Dec 31, 2024 | 741,000.00 |
| Mar 31, 2023 | 639,000.00 |
| Dec 31, 2022 | 2.77 Mn |
| Sep 30, 2022 | 7.75 Mn |
| Jun 30, 2022 | 19.89 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 7.73 Mn |
| Sep 30, 2021 | 14.86 Mn |
| Jun 30, 2021 | 46.98 Mn |
| Mar 31, 2021 | 45.32 Mn |
| Dec 31, 2020 | 48.89 Mn |
| Sep 30, 2020 | 86.70 Mn |
| Jun 30, 2020 | 123.56 Mn |
| Mar 31, 2020 | 8.79 Mn |
| Dec 31, 2019 | 15.57 Mn |
| Sep 30, 2019 | 32.12 Mn |
| Jun 30, 2019 | 50.68 Mn |
API Access
Evofem Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();